British Journal of Haematology, 0007-1048

Journal

More filtering options
  1. Glucocorticoids improve erythroid progenitor maintenance and dampen Trp53 response in a mouse model of Diamond-Blackfan anaemia.

    Sara Sjögren, Siva, K., Shamit Soneji, George, A. J., Winkler, M., Jaako, P., Wlodarski, M., Stefan Karlsson, Hannan, R. D. & Johan Flygare, 2015, In : British Journal of Haematology. 171, 4, p. 517-529

    Research output: Contribution to journalArticle

  2. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia

    Passweg, JR., Rabusin, M., Musso, M., Beguin, Y., Cesaro, S., Ehninger, G., Espigado, I., Iriondo, A., Jost, L., Koza, V., Lenhoff, S., Lisukov, I., Locatelli, F., Marmont, A., Philippe, P., Pilatrino, C., Quartier, P., Stary, J., Veys, P., Vormoor, J. & 5 othersWahlin, A., Zintl, F., Bocelli-Tyndall, C., Tyndall, A. & Gratwohl, A., 2004, In : British Journal of Haematology. 125, 6, p. 749-755

    Research output: Contribution to journalArticle

  3. Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c-Kit stimulation

    Edling, C. E., Pedersen, M., Carlsson, L., Lars Rönnstrand, Palmer, R. H. & Hallberg, B., 2007, In : British Journal of Haematology. 136, 2, p. 260-268

    Research output: Contribution to journalArticle

  4. Haemophilia B mutations in a complete Swedish population sample: a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity

    Green, P. M., Montandon, A. J., R. Ljung, Bentley, D. R., Nilsson, I. M., Kling, S. & Giannelli, F., 1991, In : British Journal of Haematology. 78, 3, p. 390-397

    Research output: Contribution to journalArticle

  5. Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity

    Rolf Ljung, Petrini, P., Tengborn, L. & Sjörin, E., 2001, In : British Journal of Haematology. 113, 1, p. 81-86

    Research output: Contribution to journalArticle

  6. HAX-1 overexpression in multiple myeloma is associated with poor survival

    Feng, X., Anna Kwiecinska, Rossmann, E., Bottai, M., Ishikawa, T., Patarroyo, M., Österborg, A., Anna Porwit, Zheng, C. & Fadeel, B., 2019, In : British Journal of Haematology. 185, 1, p. 179-183 5 p.

    Research output: Contribution to journalLetter

  7. Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy.

    Seidel, C., Lenhoff, S., Brabrand, S., Anderson, G., Standal, T., Lanng-Nielsen, J., Ingemar Turesson, Børset, M. & Waage, A., 2002, In : British Journal of Haematology. 119, 3, p. 672-676

    Research output: Contribution to journalArticle

  8. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005.

    Karrman, K., Forestier, E., Andersen, M. K., Autio, K., Borgstrom, G., Heim, S., Heinonen, K., Hovland, R., Kerndrup, G. & Bertil Johansson, 2006, In : British Journal of Haematology. 135, 3, p. 352-354

    Research output: Contribution to journalArticle

  9. Highly increased familial risks for specific lymphoma subtypes

    Goldin, L. R., Bjorkholm, M., Kristinsson, S. Y., Ingemar Turesson & Landgren, O., 2009, In : British Journal of Haematology. 146, 1, p. 91-94

    Research output: Contribution to journalArticle

  10. Homozygous deletions of CDKN2A are present in all dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation

    Zachariadis, V., Schoumans, J., Barbany, G., Heyman, M., Forestier, E., Bertil Johansson, Nordenskjold, M. & Nordgren, A., 2012, In : British Journal of Haematology. 159, 4, p. 488-491

    Research output: Contribution to journalLetter

  11. How I manage patients with inherited haemophilia A and B and factor inhibitors

    Rolf C.R. Ljung, 2018 Feb, In : British Journal of Haematology. 180, 4, p. 501-510

    Research output: Contribution to journalReview article

  12. How to manage invasive procedures in children with haemophilia.

    Rolf Ljung & Knobe, K., 2012, In : British Journal of Haematology. 157, 5, p. 519-528

    Research output: Contribution to journalArticle

  13. Hypereosinophilic syndrome in a child mosaic for a congenital triplication of the short arm of chromosome 8

    Arne Egesten, Hagerstrand, I., Ulf Kristoffersson & Garwicz, S., 1997, In : British Journal of Haematology. 96, 2, p. 369-73

    Research output: Contribution to journalArticle

  14. Identification of novel diagnostic biomarkers for deep venous thrombosis

    Ashfaque A. Memon, Kristina Sundquist, PirouziFard, M., Johan L. Elf, Strandberg, K., Peter J. Svensson, Jan Sundquist & Bengt Zöller, 2018 May 1, In : British Journal of Haematology. 181, 3, p. 378-385 8 p.

    Research output: Contribution to journalArticle

  15. Ikaros and leukaemia.

    Linda Olsson & Bertil Johansson, 2015, In : British Journal of Haematology. 169, 4, p. 479-491

    Research output: Contribution to journalReview article

  16. Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.

    Lenhoff, S., Hjorth, M., Westin, J., Brinch, L., Backstrom, B., Carlson, K., Christiansen, I., Dahl, I. M., Gimsing, P., Hammerstrom, J., Johnsen, H. E., Juliusson, G., Linder, O., Mellqvist, U-H., Nesthus, I., Nielsen, J. L., Tangen, J. M. & Turesson, I., 2006, In : British Journal of Haematology. 133, 4, p. 389-396

    Research output: Contribution to journalArticle

  17. Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

    Martino, A., Campa, D., Jamroziak, K., Reis, R. M., Sainz, J., Buda, G., Garcia-Sanz, R., Lesueur, F., Marques, H., Moreno, V., Jurado, M., Rios, R., Szemraj-Rogucka, Z., Szemraj, J., Tjonneland, A., Overvad, K., Vangsted, A. J., Vogel, U., Mikala, G., Kadar, K. & 11 othersSzombath, G., Varkonyi, J., Orciuolo, E., Dumontet, C., Gemignani, F., Rossi, A. M., Landi, S., Petrini, M., Houlston, R. S., Kari Hemminki & Canzian, F., 2012, In : British Journal of Haematology. 158, 6, p. 805-809

    Research output: Contribution to journalLetter

  18. Improved outcome after relapse in children with acute myeloid leukaemia

    Abrahamsson, J., Clausen, N., Gustafsson, G., Hovi, L., Jonmundsson, G., Zeller, B., Forestier, E., Heldrup, J. & Hasle, H., 2007, In : British Journal of Haematology. 136, 2, p. 229-236

    Research output: Contribution to journalArticle

  19. Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study

    Gunnar Juliusson, Hoglund, M., Karlsson, K., Lofgren, C., Mollgard, L., Paul, C., Tidefelt, U. & Bjorkholm, M., 2003, In : British Journal of Haematology. 123, 5, p. 810-818

    Research output: Contribution to journalArticle

  20. Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.

    Frandsen, T. L., Abrahamsson, J., Lausen, B., Vettenranta, K., Heyman, M., Behrentz, M., Anders Castor, Wehner, P. S., Frost, B-M., Andersen, E. W. & Schmiegelow, K., 2011, In : British Journal of Haematology. 155, p. 244-247

    Research output: Contribution to journalArticle

  21. Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase - a report from the Swedish CML Group

    Ingemar Turesson, Axdorph, U., Vilen, L., Stenke, L., Uden, AM., Grimfors, G., Bjorkholm, M., Carneskog, J., Hansen, J., Linder, O., Ljungman, P., Lofvenberg, E., Malm, C., Simonsson, B., Vilen, L., Uden, AM. & Bjorkholm, M., 2002, In : British Journal of Haematology. 118, 4, p. 1048-1054

    Research output: Contribution to journalArticle

  22. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment

    Gretenkort Andersson, N., Auerswald, G., Barnes, C., Carcao, M., Dunn, A. L., Fijnvandraat, K., Hoffmann, M., Kavakli, K., Kenet, G., Kobelt, R., Kurnik, K., Liesner, R., Mäkipernaa, A., Manco-Johnson, M. J., Mancuso, M. E., Molinari, A. C., Nolan, B., Perez Garrido, R., Petrini, P., Platokouki, H. E. & 3 othersShapiro, A. D., Wu, R. & Rolf Ljung, 2017, In : British Journal of Haematology. 179, 2, p. 298-307

    Research output: Contribution to journalArticle

  23. Intracranial haemorrhage in haemophilia A and B.

    Rolf Ljung, 2008, In : British Journal of Haematology. 140, 4, p. 378-384

    Research output: Contribution to journalReview article

  24. Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells

    Aslam, R., Burack, W. R., Segel, G. B., McVey, M. J., Spence, S. A. & John W. Semple, 2018, In : British Journal of Haematology. 181, p. 262-264

    Research output: Contribution to journalLetter

  25. Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.

    Nordigården, A., Zetterblad, J., Trinks, C., Green, H., Eliasson, P., Druid, P., Lotfi, K., Lars Rönnstrand, Walz, T. M. & Jönsson, J-I., 2011, In : British Journal of Haematology. 155, p. 198-208

    Research output: Contribution to journalArticle

  26. Long term risk of infections in Hodgkin lymphoma long-term survivors.

    Andersson, A., Enblad, G., Gustavsson, A., Erlanson, M., Hagberg, H., Molin, D., Tavelin, B. & Melin, B., 2011, In : British Journal of Haematology. 154, p. 661-663

    Research output: Contribution to journalLetter

  27. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis

    Lietz, A., Janz, M., Mikael Sigvardsson, Jundt, F., Doerken, B. & Mathas, S., 2007, In : British Journal of Haematology. 137, 4, p. 342-348

    Research output: Contribution to journalArticle

  28. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia

    Tzoanopoulos, D., Speletas, M., Arvanitidis, K., Veiopoulou, C., Kyriaki, S., Thyphronitis, G., Sideras, P., Kartalis, G. & Ritis, K., 2002, In : British Journal of Haematology. 119, 1, p. 46-53

    Research output: Contribution to journalArticle

  29. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

    Grovdal, M., Karimi, M., Khan, R., Aggerholm, A., Antunovic, P., Jan Astermark, Bernell, P., Engstrom, L-M., Kjeldsen, L., Linder, O., Nilsson, L., Olsson, A., Holm, M. S., Tangen, J. M., Wallvik, J., Oberg, G., Hokland, P., Jacobsen, S. E. W., Porwit, A. & Hellstrom-Lindberg, E., 2010, In : British Journal of Haematology. 150, 3, p. 293-302

    Research output: Contribution to journalArticle

  30. Major surgery seems not to influence HIV disease progression in haemophilia patients

    Jan Astermark, Löfqvist, T., Schulman, S., Stigendal, L., Lethagen, S., Nilsson, I. M. & Erik Berntorp, 1998, In : British Journal of Haematology. 103, 1, p. 10-14

    Research output: Contribution to journalArticle

  31. Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia

    Kajsa Paulsson, An, Q., Moorman, A. V., Parker, H., Molloy, G., Davies, T., Griffiths, M., Ross, F. M., Irving, J., Harrison, C. J., Young, B. D. & Strefford, J. C., 2009, In : British Journal of Haematology. 144, 6, p. 838-847

    Research output: Contribution to journalArticle

  32. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.

    Thörnerup, I., Forestier, E., Botling, J., Thuresson, B., Wasslavik, C., Björklund, E., Li, A., Lindström-Eriksson, E., Malec, M., Grönlund, E., Torikka, K., Heldrup, J., Abrahamsson, J., Behrendtz, M., Söderhäll, S., Jacobsson, S., Olofsson, T., Porwit, A., Lönnerholm, G., Rosenquist, R. & 1 othersSundström, C., 2011, In : British Journal of Haematology. 152, 6, p. 743-753

    Research output: Contribution to journalArticle

  33. Modifying the red cell surface: towards an ABO-universal blood supply

    Martin L Olsson & Clausen, H., 2008, In : British Journal of Haematology. 140, 1, p. 3-12

    Research output: Contribution to journalReview article

  34. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia

    Foster, N., Kajsa Paulsson, Sales, M., Cunningham, J., Groves, M., O'Connor, N., Begum, S., Stubbs, T., McMullan, D. J., Griffiths, M., Pratt, N. & Tauro, S., 2010, In : British Journal of Haematology. 148, 6, p. 938-943

    Research output: Contribution to journalArticle

  35. Monoclonal gammopathy of undetermined significance: to screen or not to screen for multiple myeloma? - response

    Bird, J., Behrens, J., Drayson, M. T., Ingemar Turesson & Westin, J., 2010, In : British Journal of Haematology. 149, 4, p. 621-623

    Research output: Contribution to journalLetter

  36. Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: An analysis of the Swedish Lymphoma Registry

    Molin, D., Linderoth, J. & Wahlin, B. E., 2017, In : British Journal of Haematology. 177, 3, p. 449-456

    Research output: Contribution to journalArticle

  37. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

    Geisler, C. H., Kolstad, A., Laurell, A., Jerkeman, M., Raty, R., Andersen, N. S., Pedersen, L. B., Eriksson, M., Nordstrom, M., Kimby, E., Bentzen, H., Kuittinen, O., Lauritzsen, G. F., Nilsson-Ehle, H., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M-L., Brown, P. & 1 othersElonen, E., 2012, In : British Journal of Haematology. 158, 3, p. 355-362

    Research output: Contribution to journalArticle

  38. No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.

    Jakobsen, L. H., Hutchings, M., de Nully Brown, P., Linderoth, J., Mylam, K. J., Molin, D., Johnsen, H. E., Bøgsted, M., Mats Jerkeman & El-Galaly, T. C., 2016, In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  39. Novel alleles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families.

    Irshaid, N. M., Eicher, N. I., Hustinx, H., Poole, J. & Martin L Olsson, 2002, In : British Journal of Haematology. 116, 2, p. 445-453

    Research output: Contribution to journalArticle

  40. Origin of mutation in sporadic cases of haemophilia A

    R. C R Ljung & Sjörin, E., 1999, In : British Journal of Haematology. 106, 4, p. 870-874

    Research output: Contribution to journalArticle

  41. Outcome of an enhanced diagnostic pipeline for patients suspected of inherited thrombocytopenia

    Leinøe, E., Gabrielaite, M., Østrup, O., Funding, E., Greinacher, A., Ostrowski, S. R., Eva Zetterberg & Rossing, M., 2019, In : British Journal of Haematology.

    Research output: Contribution to journalLetter

  42. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival

    Forestier, E., Heyman, M., Andersen, M. K., Autio, K., Blennow, E., Borgstrom, G., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Johannsson, J. H., Kerndrup, G., Nordgren, A., Rosenquist, R., Swolin, B. & Bertil Johansson, 2008, In : British Journal of Haematology. 140, 6, p. 665-672

    Research output: Contribution to journalArticle

  43. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.

    Andersen, M. K., Autio, K., Barbany, G., Borgström, G., Cavelier, L., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Johannsson, J. H., Bertil Johansson, Kjeldsen, E., Nordgren, A., Palmqvist, L. & Forestier, E., 2011, In : British Journal of Haematology. 155, p. 235-243

    Research output: Contribution to journalArticle

  44. Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study

    Sverrisdóttir, I. S., Lund, S. H., Ingemar Turesson, Björkholm, M., Goldin, L. R., Landgren, O. & Kristinsson, S. Y., 2019, In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  45. Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

    d'Amore, F., Radford, J., Relander, T., Mats Jerkeman, Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H., 2010, In : British Journal of Haematology. 150, 5, p. 565-573

    Research output: Contribution to journalArticle

  46. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura

    Manea Hedström, M., Ann-Charlotte Kristoffersson, Schneppenheim, R., Saleem, M. A., Mathieson, P. W., Mörgelin, M., Björk, P., Lars Holmberg & Diana Karpman, 2007, In : British Journal of Haematology. 138, 5, p. 651-662

    Research output: Contribution to journalArticle